Mark A. Collar, Director at AtriCure, Inc. (ATRC), sold 670 shares at $40.20 ($27K) on 2020-10-01, disclosed to the SEC on 2020-10-05.
Scheduled sale ($27k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2021-04-05 | $196K | — | Filing → |
| ATRC | SELL | 2021-01-06 | $166K | — | Filing → |
| ATRC | SELL | 2020-10-08 | $93K | — | Filing → |